Oxidation of CaMKII determines the cardiotoxic effects of aldosterone

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature Medicine

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2506PMID 22081025PMCID PMC3332099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidized CaMKII causes cardiac sinus node dysfunction in mice.

  2011cited by this paper
• Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial.

  2010cited by this paper
• Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.

  2010cited by this paper
• Sudden Cardio Arrest: Oxidative stress irritates the heart

  2010cited by this paper
• Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

  2010cited by this paper
• Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.

  2009cited by this paper
• Oxidized Calmodulin Kinase II Regulates Conduction Following Myocardial Infarction: A Computational Analysis

  2009cited by this paper
• Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice.

  2009cited by this paper
• The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

  2009cited by this paper
• Global patterns of mortality in young people: a systematic analysis of population health data.

  2009cited by this paper
• Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways.

  2009cited by this paper
• IL‐1β induces MMP‐9 expression via a Ca2+‐dependent CaMKII/JNK/c‐JUN cascade in rat brain astrocytes

  2009cited by this paper
• Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction.

  2009cited by this paper
• Aldosterone induces superoxide generation via Rac1 activation in endothelial cells.

  2008cited by this paper
• A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.

  2008cited by this paper
• A protocol for in vivo detection of reactive oxygen species

  2008cited by this paper
• Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury

  2008cited by this paper
• Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase II

  2008cited by this paper
• The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.

  2008cited by this paper
• Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart

  2008cited by this paper
• Quantitative proteomics using stable isotope labeling with amino acids in cell culture

  2008cited by this paper
• Defining the Cellular Phenotype of “Ankyrin-B Syndrome” Variants: Human ANK2 Variants Associated With Clinical Phenotypes Display a Spectrum of Activities in Cardiomyocytes

  2007cited by this paper
• Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction

  2007cited by this paper
• Computational Analysis

  2007cited by this paper
• Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).

  2007cited by this paper
• Role of matrix metalloproteinases in delayed cortical responses after stroke

  2006cited by this paper
• Aldosterone mediates angiotensin II‐induced interstitial cardiac fibrosis via a Nox2‐containing NADPH oxidase

  2006cited by this paper
• High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction

  2006cited by this paper
• Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.

  2006cited by this paper
• Calcific Aortic Valve Stenosis in Old Hypercholesterolemic Mice

  2006cited by this paper
• Death, Cardiac Dysfunction, and Arrhythmias Are Increased by Calmodulin Kinase II in Calcineurin Cardiomyopathy

  2006cited by this paper
• Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

  2006cited by this paper
• CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.

  2006cited by this paper
• Aldosterone Stimulates Matrix Metalloproteinases and Reactive Oxygen Species in Adult Rat Ventricular Cardiomyocytes

  2005cited by this paper
• Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

  2005cited by this paper
• Calmodulin kinase II inhibition protects against structural heart disease

  2005cited by this paper
• Possible Association of Heart Failure Status With Synthetic Balance Between Aldosterone and Dehydroepiandrosterone in Human Heart

  2004cited by this paper
• Requirement for Rac1-Dependent NADPH Oxidase in the Cardiovascular and Dipsogenic Actions of Angiotensin II in the Brain

  2004cited by this paper
• Cardiac rupture complicating myocardial infarction.

  2004cited by this paper
• Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants

  2003cited by this paper
• Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment

  2003cited by this paper
• Randomised, placebo-controlled trial

  2002cited by this paper
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

  2002cited by this paper
• MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.

  2002cited by this paper
• Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.

  2002cited by this paper
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Aldosterone in congestive heart failure.

  2001cited by this paper
• Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice: Role of Oxidative Stress

  2000cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy.

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• P47phox ‐deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J‐m db/db and db/+

  2000cited by this paper
• Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

  1999cited by this paper
• Murine Matrix Metalloproteinase 9 Gene

  1999cited by this paper
• MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene.

  1999cited by this paper
• Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

  1997cited by this paper
• Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.

  1997cited by this paper
• The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction

  1995cited by this paper
• The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.

  1995cited by this paper
• Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure.

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

  1982cited by this paper
• Cardiac rupture complicating myocardial infarction.

  1981cited by this paper
• Enzymatic reduction of protein-bound methionine sulfoxide.

  1981cited by this paper
• Binding of aldosterone to cytoplasmic and nuclear receptors of the urinary bladder epithelium of Bufo marinus.

  1978cited by this paper
• Aldosterone in congestive heart failure.

  1959cited by this paper

• Elevated plasma aldosterone-to-renin ratio as a potential risk marker of adverse left ventricular remodeling: a cross-sectional study

  2026cites this paper
• CaMKII in the Heart: From Homeostasis to Pathology.

  2026cites this paper
• Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation

  2025cites this paper
• HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease

  2025cites this paper
• Methionine sulfoxide reductase A deficiency impairs zebrafish heart regeneration via inhibiting Prohibitin 2-Pink1-mediated mitophagy.

  2025cites this paper
• Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice

  2025cites this paper
• Methionine sulfoxide reductase A deficiency aggravated ferroptosis in LPS-induced acute kidney injury by inhibiting the AMPK/NRF2 axis and activating the CaMKII/HIF-1α pathway.

  2025cites this paper
• Danhong Injection targets CaMKII through Dihydrotanshinone I to alleviate cardiomyocyte death and inflammation in viral myocarditis.

  2025cites this paper
• Nuclear CaMKII Isoforms as Regulators of Transcription: From Developmental to Pathological Persistence

  2025cites this paper
• Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.

  2025cites this paper
• Familial Hyperaldosteronism: an ENDO ERN Clinical Practice Guideline.

  2024cites this paper
• Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model

  2024cites this paper
• Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology

  2024cites this paper
• Tetramethylpyrazine Protects Against Chronic Hypobaric Hypoxia-Induced Cardiac Dysfunction by Inhibiting CaMKII Activation in a Mouse Model Study

  2024cites this paper
• The Potential Mechanisms of Catechins in Tea for Anti-Hypertension: An Integration of Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

  2024cites this paper
• The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease

  2024cites this paper
• Verapamil inhibits inflammation and promotes autophagy to alleviate ureteral scar by regulation of CaMK IIδ/STAT3 axis

  2024cites this paper
• Unveiling the role of CaMKII in retinal degeneration: from biological mechanism to therapeutic strategies

  2024cites this paper
• Development and Optimization of a Redox Enzyme-Based Fluorescence Biosensor for the Identification of MsrB1 Inhibitors

  2024cites this paper
• Emerging Role of CaMKII as a Possible Therapeutic Target for Cardiovascular Diseases

  2024cites this paper
• JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes

  2024cites this paper
• CaMKIIδ gene editing- A base hit for the heart

  2023cites this paper
• The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-β/Smad and RAF/ERK Pathways

  2023cites this paper
• The Effect of Aldosterone on Cardiorenal and Metabolic Systems

  2023cites this paper
• An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor

  2023cites this paper
• Effect of Colchicine in reducing MMP-9, NOX2, and TGF- β1 after myocardial infarction

  2023cites this paper
• The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2.

  2023cites this paper
• Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors

  2023cites this paper
• CaMKII, 'jack of all trades' in inflammation during cardiac ischemia/reperfusion injury.

  2023cites this paper
• Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model

  2023cites this paper
• Colchicine as potential inhibitor targeting MMP-9, NOX2 and TGF-β1 in myocardial infarction: a combination of docking and molecular dynamic simulation study

  2023cites this paper
• Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy

  2023cites this paper
• Nicotinamide Adenosine Dinucleotide Phosphate Oxidase-Mediated Signaling in Cardiac Remodeling

  2023cites this paper
• Berberine Ameliorates Diabetic Cardiomyopathy in Mice by Decreasing Cardiomyocyte Apoptosis and Oxidative Stress

  2023cites this paper
• Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage

  2023cites this paper
• CRISPR Editing Takes Aim at Ischemia/Reperfusion Injury.

  2023cites this paper
• Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria

  2023cites this paper
• CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure

  2022cites this paper
• Emerging therapeutic targets for cardiac hypertrophy

  2022cites this paper
• Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation

  2022cites this paper
• Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects

  2022influential citation
• Pathological implication of CaMKII in NF-κB pathway and SASP during cardiomyocytes senescence.

  2022cites this paper
• Oxidative stress–induced autonomous activation of the calcium/calmodulin-dependent kinase II involves disulfide formation in the regulatory domain

  2022cites this paper
• Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.

  2022cites this paper
• Novel Biosensor Identifies Ruxolitinib as a Potent and Cardioprotective CaMKII Inhibitor

  2022cites this paper
• NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction

  2022influential citation
• Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism

  2022cites this paper
• Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction

  2022cites this paper
• CaMKII as a Therapeutic Target in Cardiovascular Disease

  2022influential citation
• Aldosterone as a Mediator of Cardiovascular Damage.

  2022cites this paper
• Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth

  2022cites this paper
• The selenoprotein methionine sulfoxide reductase B1 (MSRB1).

  2022cites this paper
• CaMKII inhibition protects against hyperthyroid arrhythmias and adverse myocardial remodeling.

  2022cites this paper
• Perturbation of biological processes with small molecule kinase inhibitors.

  2022cites this paper
• Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects

  2021cites this paper
• Role of oxidative stress in calcific aortic valve disease and its therapeutic implications

  2021cites this paper
• CaMKII Serine 280 O-GlcNAcylation Links Diabetic Hyperglycemia to Proarrhythmia

  2021cites this paper
• CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury

  2021cites this paper
• CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy

  2021cites this paper
• Interactive Roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.

  2021cites this paper
• Infarct in the Heart: What’s MMP-9 Got to Do with It?

  2021cites this paper
• An NMR-based biosensor to measure stereo-specific methionine sulfoxide reductase (MSR) activities in vitro and in vivo

  2020cites this paper
• Thiadiazolidinone-8, a GSK3β inhibitor, ameliorates aldosterone-induced cardiac inflammation and fibrosis by regulating autophagy

  2020cites this paper
• Oxidative Stress in Heart Failure

  2020cites this paper
• Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism

  2020cites this paper
• Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart

  2020cites this paper
• Bisphenol A induces coronary endothelial cell necroptosis by activating RIP3/CamKII dependent pathway

  2020cites this paper
• Persulfide Signaling in Stress-Initiated Calmodulin Kinase Response

  2020cites this paper
• O-GlcNAcylation and oxidation contribute to atrial fibrillation in diabetes by activating CaMKII

  2020cites this paper
• Oxidative Stress Orchestrates MAPK and Nitric-Oxide Synthase Signal

  2020cites this paper
• The Role of CaMKII Overexpression and Oxidation in Atrial Fibrillation—A Simulation Study

  2020cites this paper
• Oxidized-CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms.

  2020cites this paper
• O-GlcNAcylation, oxidation and CaMKII contribute to atrial fibrillation in type 1 and type 2 diabetes by distinct mechanisms

  2020cites this paper
• CaMKII exacerbates heart failure progression by activating class I HDACs.

  2020cites this paper
• Modulating ALDH2 reveals a differential dependence on ROS for hypertrophy and SR Ca2+ release in aldosterone-treated cardiac myocytes.

  2020cites this paper
• An NMR-based biosensor to measure stereo-specific methionine sulfoxide reductase (MSR) activities in vitro and in vivo.

  2020cites this paper
• Role of Oxidation-Dependent CaMKII Activation in the Genesis of Abnormal Action Potentials in Atrial Cardiomyocytes: A Simulation Study

  2020cites this paper
• The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases

  2020cites this paper
• Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure

  2020cites this paper
• Excessive O - GlcNAcylation causes heart failure and sudden death

  2020cites this paper
• MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII.

  2020cites this paper
• The Scientific Basis of Heart Failure

  2019cites this paper
• Enalapril attenuates endoplasmic reticulum stress and mitochondrial injury induced by myocardial infarction via activation of the TAK1/NFAT pathway in mice

  2019cites this paper
• Unique mechanistic insights into the beneficial effects of angiotensin‐(1–7) on the prevention of cardiac fibrosis: A metabolomic analysis of primary cardiac fibroblasts

  2019cites this paper
• CaMKII Activity in the Inflammatory Response of Cardiac Diseases

  2019cites this paper
• Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy

  2019cites this paper
• CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair

  2019cites this paper
• Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKIIδ oxidation

  2019cites this paper
• Association between elevated plasma aldosterone concentration and left atrial conduit function in hypertension

  2019cites this paper
• Oxidative CaMKII as a potential target for inflammatory disease (Review).

  2019cites this paper
• Apolipoprotein-J blocks increased cell injury elicited by ox-LDL via inhibiting ROS-CaMKII pathway

  2019cites this paper
• Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2

  2019cites this paper
• Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

  2019cites this paper
• The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?

  2018cites this paper
• Defective protein repair under methionine sulfoxide A deletion drives autophagy and ARE-dependent gene transcription

  2018cites this paper
• The Novel Tumor Supressive Role of Epithelial-Derived Matrix Metalloproteintase 9 In Colitis Associated Cancer

  2018cites this paper
• Physiology and pathology of cardiac CaMKII

  2018cites this paper
• The Oxidized Protein Repair Enzymes Methionine Sulfoxide Reductases and Their Roles in Protecting against Oxidative Stress, in Ageing and in Regulating Protein Function

  2018cites this paper
• Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice

  2018cites this paper
• Trimetazidine suppresses oxidative stress, inhibits MMP‐2 and MMP‐9 expression, and prevents cardiac rupture in mice with myocardial infarction

  2018cites this paper